Streetbeat News

Stock Prices

RMD

ResMed (NYSE:RMD) has outperformed the market over the past 20 years by 8.89% on an annualized basis, producing an average annual return of 16.6%. If an investor had bought $100 of RMD stock 20 years ago, it would be worth $2,198.84 today.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 2:01 pm

CCI

Crown Castle (NYSE:CCI) has received 5 somewhat bullish and 4 indifferent analyst ratings in the last quarter. The average 12-month price target for the company is $142.78, representing a 5.6% decrease from the previous average price target of $151.25.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 2:01 pm

ABC

AmerisourceBergen (NYSE:ABC) has outperformed the market over the past 10 years, producing an average annual return of 12.75%. If an investor had bought $1000 of ABC stock 10 years ago, it would be worth $3,322.60 today.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 2:00 pm

THTX

Theratechnologies (NASDAQ:THTX) is set to release its latest quarterly earnings report on Wednesday, 2023-07-12. Analysts estimate an earnings per share (EPS) of $-0.10. The company's past performance shows a pattern of EPS misses followed by share price increases. The stock is currently trading at $0.8988, down 55.61% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 2:00 pm

AVY

Avery Dennison (NYSE:AVY) has received 4 bullish and 2 somewhat bullish ratings from analysts in the last quarter. The average price target is $186.5, implying an upside from the current price of $174.2. However, this average has decreased by 1.95% from the previous average price target of $190.20.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 2:00 pm

ANGO

AngioDynamics (NASDAQ:ANGO) is set to release its latest quarterly earnings report on Wednesday, 2023-07-12. Analysts estimate an earnings per share (EPS) of $0.02. The company's past performance shows a mixed trend of beating and missing EPS estimates, with corresponding changes in share price. The stock is currently trading at $9.62, down 54.16% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 2:00 pm

AAPL

HOOD

META

MSFT

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo discusses the trade strategy for SPY, QQQ, AAPL, META, MSFT, TSLA, and HOOD. The memo provides price levels for these stocks based on a proprietary formula that takes into account price, volume, and options flow. The memo suggests that traders should monitor these stocks closely and be prepared to leverage potential breakouts or reversals.

Portfolio Pulse from RIPS

July 11, 2023 | 1:56 pm

ADIL

Adial Pharmaceuticals' shares are trading higher following positive feedback from US and EU regulatory meetings. The company provided a business update which has been well received by the market.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 1:54 pm

AAPL

AMZN

GOOGL

INTC

META

MSFT

NVDA

ORCL

QCOM

SBUX

TSLA

Nasdaq has announced a special rebalance of the Nasdaq 100 on July 24th, an event that has only occurred once before in 2011. The rebalance will not change the securities within the index, but will adjust the weightings of each constituent. The last rebalance in 2011 saw a temporary negative reaction to the index and a reduction in the weightings of Apple, QCOM, and SBUX, while MSFT, ORCL, INTC, and GOOGL saw increases. The upcoming rebalance could potentially impact the 'Magnificent 7' (AAPL, NVDA, MSFT, TSLA, META, GOOGL, AMZN).

Portfolio Pulse from Thrasher Analytics

July 11, 2023 | 1:51 pm

ADCT

ADIL

BTTX

DSS

GDTC

SYTA

US stocks traded mostly higher with the Dow up 0.40% and the NASDAQ up 0.23%. The NFIB Small Business Optimism Index rose to a seven-month high of 91 in June. CytoMed Therapeutics, Adial Pharmaceuticals, and Better Therapeutics saw significant stock increases, while Siyata Mobile, ADC Therapeutics, and DSS, Inc. experienced drops. The US continues to lead in COVID-19 cases and deaths.

Portfolio Pulse from Lisa Levin

July 11, 2023 | 1:48 pm